https://www.selleckchem.com/pr....oducts/Erlotinib-Hyd
1 ± 5.7 years (range, 20 to 30 years). The seroprevalence rates of IgG antibodies against (28.51% vs. 4.68%; = 34.85, 0.01) and (24.26% vs. 5.11%; = 25.77, 0.01) were both significantly higher in the observation group than in the control group, and the seroprevalence of and co-infections was also significantly greater in the observation group than in the control group (13.19% vs. 2.13%; = 17.49, 0.01). The seroprevalence rates of and infections and their co-infections are all high among pregnant women in H
Like
Comment
Share
